Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01800604 · ClinicalTrials.gov registry record · NA

Power Over Pain (POP) Study

A NA study of Multiple Sclerosis and Chronic Pain, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
177
Enrollment target
1
Study location

NCT01800604: Completed NA study of Multiple Sclerosis and Chronic Pain, sponsored by University of Washington.

NCT01800604 is a NA study of Multiple Sclerosis and Chronic Pain that has completed, run by University of Washington. The registered enrollment target is 177 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01800604, a NA study of Multiple Sclerosis and Chronic Pain, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
177 participants
Enrollment target
1
Study location

Study Summary

Many individuals with multiple sclerosis (MS), spinal cord injury (SCI), acquired amputation (AMP), muscular dystrophy (MD), and low back pain (LBP) experience pain. There has been little research on how to treat this pain. Different types of treatment that include self-hypnosis, education about chronic pain, and learning skills on how to change how a person thinks about his/her pain have been used to treat chronic pain in the general population. The purpose of this study is to see if these different treatments can help decrease pain in people with multiple sclerosis and spinal cord injury, and determine how and why these treatments are effective. A subject must have a diagnosis of MS,SCI, AMP, MD, or LBP, have chronic pain, and be at least 18 years old to participate.

Primary Outcome

Average pain intensity will be assessed via telephone interviews using a 0-10 numerical rating scale (NRS) of average pain in the past 24 hours, four times within a 1-week period at each assessment point. The change in mean of these ratings will be used as the primary outcome measure of average daily pain intensity.

Interventions

  • BEHAVIORAL Pain Self-Management Intervention #1
  • BEHAVIORAL Pain Self-Management Intervention #2
  • BEHAVIORAL Pain Self-Management Intervention #3
  • BEHAVIORAL Pain Self-Management Intervention #4

Study Locations (1)

Washington

  • University of Washington, Ninth and Jefferson Building - Seattle

Trial Details

FieldValue
Enrollment Target 177 participants
Start Date 2013-02
Est. Completion 2018-01
Phase NA
University of Washington

1,048 total trials

What the finished NCT01800604 record still lists

NCT01800604 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (70% lower).

The record links to 6 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 4 interventions - of which Pain Self-Management Intervention #1 is the first listed.

NCT01800604 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT01800604 about?

NCT01800604 is a clinical study titled "Power Over Pain (POP) Study". Many individuals with multiple sclerosis (MS), spinal cord injury (SCI), acquired amputation (AMP), muscular dystrophy (MD), and low back pain (LBP) experience pain. There has been little research on how to treat this pain. Different types of treatment that include self-hypnosis, education about chr...

What is the current status of trial NCT01800604?

This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2013-02. Estimated completion is 2018-01.

What conditions does trial NCT01800604 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Chronic Pain, Low Back Pain, Spinal Cord Injury, Muscular Dystrophies.

What interventions are being tested in trial NCT01800604?

The interventions under investigation include: Pain Self-Management Intervention #1 (BEHAVIORAL), Pain Self-Management Intervention #2 (BEHAVIORAL), Pain Self-Management Intervention #3 (BEHAVIORAL), Pain Self-Management Intervention #4 (BEHAVIORAL).

Who is sponsoring clinical trial NCT01800604?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01800604 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01800604's enrollment target sits among peer trials

177 84th of 315 higher than 232 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05491551 · 177 participants · NA

    Alcohol-ROC-Training

  • NCT06108050 · 177 participants · Phase 1

    JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

  • NCT06575712 · 177 participants · NA

    Coping Skills Training for Symptom Management and Daily Steps (Step Up)

  • NCT06674980 · 177 participants · NA

    Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01800604, the US trial registry maintained by the National Library of Medicine. NCT01800604 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.